Navigating a cancer diagnosis is difficult, and even more so during a global pandemic.
The FY20 Defense Appropriations Act provides funding to the Department of Defense Pancreatic Cancer Research Program to support a collaborative pancreatic cancer research paradigm that reduces the burden of pancreatic cancer.
The FY20 Defense Appropriations Act provides funding to the Department of Defense Rare Cancers Research Program to support for research of exceptional scientific merit in the area of rare cancers research. The RCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY20... […]
EGFR Resisters and LUNGevity Foundation have issued a Request for Application for the EGFR-Positive lung cancer research program.
The FY20 Defense Appropriations Act provides funding to the Department of Defense Pancreatic Cancer Research Program to support pancreatic cancer research.
The Hope Foundation for Cancer Research, the public charity supporting SWOG Cancer Research Network, is launching the John Crowley, PhD, Award, to encourage statistical excellence in clinical trials.
The FY20 Defense Appropriations Act is anticipated to provide funding to the Department of Defense Ovarian Cancer Research Program to support patient-centered research to prevent, detect, treat, and cure ovarian cancer.
The FY20 Defense Appropriations Act provides funding to the Department of Defense Lung Cancer Research Program to support innovative, high-impact lung cancer research.
The Neuroendocrine Tumor Research Foundation provided $3.5 million in neuroendocrine tumor research grants to 12 projects to find more precise treatments for the cancer.
ALK Positive/LUNGevity is requesting applications for the 2020 ALK-positive Lung Cancer Research Award. Letters of intent are due Feb. 14.
